A Phase I Study of MEDI3617 in Patients with Advanced Solid Tumors
[Protocol 11-052] |
Rizvi, Naiyer, MD |
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] |
Keohan, Mary, MD |
A Phase I/II Trial of AUY-922 in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib
[Protocol 11-015] |
Riely, Gregory, MD, PhD |
A Phase IB Study of BIBW 2992 plus Cetuximab in Patients with Non-Small Cell Lung Cancer Progressing After Erlotinib or Gefitinib
[Protocol 10-078] |
Janjigian, Yelena, MD |
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors
[Protocol 11-117] |
Schwartz, Gary, MD |
A Phase Ib Study of MDX-1106 in Patients with Selected Advanced or Recurrent Malignancies
[Protocol 09-012] |
Carvajal, Richard, MD |
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114] |
Riely, Gregory, MD, PhD |
A Phase II Study of PF-00299804 in Patients with Untreated Advanced Lung Adenocarcinoma
[Protocol 10-080] |
Kris, Mark, MD |
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma
[Protocol 10-134] |
Krug, Lee, MD |
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053] |
Krug, Lee, MD |
A Phase II Trial of Erlotinib in Patients with Resected, Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor Mutations
[Protocol 08-152] |
Azzoli, Christopher, MD |
A Phase III Study of Gemcitabine-Cisplatin Alone or with Necitumumab as Initial Therapy for Patients with Stage IV Squamous Non-Small Cell Lung Cancer
[Protocol 11-076] |
Paik, Paul, MD |
A Survey of Psychosocial Needs and Exploration of Online Support for Patients with Pleural Mesothelioma
[Protocol 11-066] |
Key, Richard, MD |
Immunization of Small Cell Lung Cancer Patients with a Pentavalent Vaccine
[Protocol 08-095] |
Krug, Lee, MD |
Phase II Study of ADI-PEG 20 in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer
[Protocol 10-161] |
Krug, Lee, MD |
Phase II Study of Neoadjuvant Pemetrexed Plus Cisplatin for Patients with Resectable Non-Squamous Non-Small Cell Lung Cancer with "Switch Chemotherapy Alternative" in Non-Responders (NEOSCAN)
[Protocol 11-106] |
Azzoli, Christopher, MD |
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003] |
Rimner, Andreas, MD |
Physical Activity Intervention for Lung Cancer Survivors
[Protocol 08-067] |
Ostroff, Jamie, PhD |
Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Lobectomy versus Thoracotomy and Lobectomy
[Protocol 05-006] |
Rizk, Nabil, MD |
Use of High-Resolution Structural MRI to Assess Changes in Brain Structure Related to Chemotherapy in Patients with Non-Small Cell Lung Cancer: A Prospective Study
[Protocol 11-145] |
Root, James, MD |
